ArticleBioengineering (Basel, Switzerland)2024
arterioscope.sim: Enabling Simulations of Blood Flow and Its Impact on Bioimpedance Signals.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesEarly detection of cardiovascular diseases and their pre-existing conditions, arteriosclerosis and atherosclerosis, is crucial to increasing a patient's chance of survival. While imaging technologies and invasive procedures provide a reliable diagnosis, they carry high costs and risks for patients. This study aims to explore impedance plethysmography (IPG) as a non-invasive and affordable alternative for diagnosis.
methodsTo address the current lack of large-scale, high-quality impedance data, we introduce arterioscope.sim, a simulation platform that models arterial blood flow and computes the electrical conductivity of blood. The platform simulates bioimpedance measurements on specific body segments using patient-specific parameters. The study investigates how introducing arterial diseases into the simulation affects the bioimpedance signals.
resultsThe simulation results demonstrate that introducing atherosclerosis and arteriosclerosis leads to significant changes in the computed signals compared to simulations of healthy arteries. Furthermore, simulation of a patient-specific healthy artery strongly correlates with measured signals from a healthy volunteer. CONCLUSIONS AND SIGNIFICANCE: arterioscope.sim effectively simulates bioimpedance signals in healthy and diseased arteries and highlights the potential of using these signals for early diagnosis of arterial diseases, offering a non-invasive and cost-effective alternative to traditional diagnostic methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.